Clinical Trials Related to Regeneron Pharmaceuticals

Related studies linked through entity extraction aliases.

Efficacy and Safety of Alirocumab Versus Placebo on Top of Maximally Tolerated Lipid Lowering Therapy in Patients With Hypercholesterolemia Who Have Type 1 or Type 2 Diabetes and Are Treated With Insulin (ODYSSEY DM - Insulin)

Status: COMPLETED
Phase: PHASE3

Evaluation of Physician Knowledge of Safety and Safe Use Information for Aflibercept in Canada

Status: COMPLETED
Phase: N/A

Efficacy and Safety of Alirocumab in Patients With Hypercholesterolemia Not Adequately Controlled With Non-statin Lipid Modifying Therapy or the Lowest Strength of Statin

Status: COMPLETED
Phase: PHASE3

Managing Neovascular (Known as "Wet") Age-related Macular Degeneration Over 2 Years Using Different Treatment Schedules of 2 mg Intravitreal Aflibercept Injected in the Eye

Status: COMPLETED
Phase: PHASE4

Evaluation of Dupilumab's Effects on Airway Inflammation in Patients With Asthma

Status: COMPLETED
Phase: PHASE2

Treatment of Diabetic Macular Edema With Aflibercept in Subjects Previously Treated With Ranibizumab or Bevacizumab

Status: COMPLETED
Phase: PHASE4

Caregiver Burden of Wet Age-related Macular Degeneration (wAMD) in Japan

Status: COMPLETED
Phase: N/A

To Describe the Use of Intravitreal Aflibercept and to Describe Follow-up as Well as Treatment Patterns in Patients With Wet Age-related Macular Degeneration (wAMD) or Diabetic Macular Edema (DME) in Routine Clinical Practice in Canada.

Status: COMPLETED
Phase: N/A

Evaluation of Dupilumab in Patients With Severe Steroid Dependent Asthma

Status: COMPLETED
Phase: PHASE3

Companion Study for Patients Who Completed Participation in a REGN2810 (Anti-PD-1) Clinical Study

Status: WITHDRAWN
Phase: PHASE1

Study of Fasinumab (REGN475) in Healthy Japanese and Caucasian Subjects

Status: COMPLETED
Phase: PHASE1

Peripheral and Macular Retinal Vascular Perfusion and Leakage in DME and RVO

Status: COMPLETED
Phase: PHASE4

Safety, Tolerability, and Effect of Alirocumab in High Cardiovascular Risk Patients With Severe Hypercholesterolemia Not Adequately Controlled With Conventional Lipid-modifying Therapies (ODYSSEY APPRISE)

Status: COMPLETED
Phase: PHASE3

IAI Versus Sham as Prophylaxis Against Conversion to Neovascular AMD

Status: COMPLETED
Phase: PHASE2

Study of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip

Status: COMPLETED
Phase: PHASE2/PHASE3

Study of Intravitreal REGN2176-3 in Participants With Neovascular ("Wet") Age-Related Macular Degeneration (AMD)

Status: TERMINATED
Phase: PHASE2

Evaluation of Dupilumab in Patients With Persistent Asthma (Liberty Asthma Quest)

Status: COMPLETED
Phase: PHASE3

A Study to Determine the Safety and Tolerability of Dupilumab (REGN668/SAR231893) in Patients Aged ≥6 to <18 Years With Atopic Dermatitis (Eczema)

Status: COMPLETED
Phase: PHASE2

Single-dose Study to Describe the Safety of Sarilumab and Tocilizumab in Patients With Rheumatoid Arthritis

Status: COMPLETED
Phase: PHASE1

Japanese Phase 3 Study of Aflibercept in Neovascular Glaucoma Patients

Status: COMPLETED
Phase: PHASE3